IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5224.73M
Enterprise Value 3130.95M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)297.65
Price/Book (mrq)2.64
Enterprise Value/Revenue 3173.45
Enterprise Value/EBITDA 6-2.15

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-8,167.81%

Management Effectiveness

Return on Assets (ttm)-42.15%
Return on Equity (ttm)-82.01%

Income Statement

Revenue (ttm)755k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-12.80%
Gross Profit (ttm)-18.52M
EBITDA -60.97M
Net Income Avi to Common (ttm)-65.58M
Diluted EPS (ttm)-2.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)94.05M
Total Cash Per Share (mrq)3.46
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.96
Book Value Per Share (mrq)3.13

Cash Flow Statement

Operating Cash Flow (ttm)-52.04M
Levered Free Cash Flow (ttm)-24.27M

Trading Information

Stock Price History

Beta 1.63
52-Week Change 3-54.09%
S&P500 52-Week Change 315.37%
52 Week High 322.96
52 Week Low 35.20
50-Day Moving Average 38.25
200-Day Moving Average 311.93

Share Statistics

Avg Vol (3 month) 3493.41k
Avg Vol (10 day) 3381.65k
Shares Outstanding 527.17M
Float 19.44M
% Held by Insiders 112.67%
% Held by Institutions 139.75%
Shares Short (Aug 31, 2018) 4462.62k
Short Ratio (Aug 31, 2018) 40.56
Short % of Float (Aug 31, 2018) 42.45%
Short % of Shares Outstanding (Aug 31, 2018) 41.70%
Shares Short (prior month Jul 31, 2018) 4184.98k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/8
Last Split Date 3Jul 30, 2018